A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 165
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PS
Long Form : pulmonary surfactant
No. Year Title Co-occurring Abbreviation
2019 Budesonide and Poractant Alfa prevent bronchopulmonary dysplasia via triggering SIRT1 signaling pathway. BPD, NRDS, PBMCs, ROS, SIRT1, SUMO
2019 Correlation between serum transforming growth factor beta1, interleukin-6 and neonatal respiratory distress syndrome. ELISA, IL-6, NRDS, TGF-beta1
2019 Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis. BPD, ICS, MDI, NRDS, RR
2019 Evaluation of inhaled recombinant human insulin dry powders: pharmacokinetics, pharmacodynamics and 14-day inhalation. PHT, rh-insulin
2019 History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea. RDS
2019 Influence of temperature on dynamic surface properties of spread DPPC monolayers in a broad range of surface pressures. DPPC
2019 Interaction of industrial smelting soot particles with pulmonary surfactant: Pulmonary toxicity of heavy metal-rich particles. ---
2019 Interaction of inhalable volatile organic compounds and pulmonary surfactant: Potential hazards of VOCs exposure to lung. EPS, VOCs
2019 Interaction of nano carbon particles and anthracene with pulmonary surfactant: The potential hazards of inhaled nanoparticles. NCPs, NPs, PAHs
10  2019 Interaction of pulmonary surfactant with silica and polycyclic aromatic hydrocarbons: Implications for respiratory health. PAHs
11  2019 The new application of point-of-care lung ultrasound in guiding or assisting neonatal severe lung disease treatment based on a case series. BAL, LUS, POC-LUS
12  2019 Understanding the principle biophysics concepts of pulmonary surfactant in health and disease. ---
13  2018 Aggregation State of Metal-Based Nanomaterials at the Pulmonary Surfactant Film Determines Biophysical Inhibition. CDS, MNMs
14  2018 Gender-related efficacy of pulmonary surfactant in infants with respiratory distress syndrome: A STROBE compliant study. RDS
15  2018 GLP-1 Analogue Liraglutide Enhances SP-A Expression in LPS-Induced Acute Lung Injury through the TTF-1 Signaling Pathway. ALI, ATII, GLP-1, LPS, SP-A, TTF-1
16  2018 Knockout of microRNA‑26a promotes lung development and pulmonary surfactant synthesis. AECIIs, miR
17  2018 Polarized light microscopy reveals physiological and drug-induced changes in surfactant membrane assembly in alveolar type II pneumocytes. LBs, PL, PM
18  2018 Pulmonary surfactant and drug delivery: Focusing on the role of surfactant proteins. SPs
19  2018 Pulmonary surfactant-associated proteins and inflammatory factors in obstructive sleep apnea. AHI, BALF, OSA
20  2018 Role of Lipid Coating in the Transport of Nanodroplets across the Pulmonary Surfactant Layer Revealed by Molecular Dynamics Simulations. ---
21  2018 Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy. siRNA, SP-B
22  2018 Synthesis of phosphatidylcholine in rats with oleic acid-induced pulmonary edema and effect of exogenous pulmonary surfactant on its De Novo synthesis. ALI, ARDS, BALF, cpm, DSPC, LT, OA, OA-PS, PC, PE, SR, TP, TPL
23  2018 [A review on neonatal acute respiratory distress syndrome]. ARDS
24  2018 [Clinical effect of bubble nasal continuous positive airway pressure versus conventional nasal continuous positive airway pressure in respiratory support for preterm infants with neonatal respiratory distress syndrome]. B-NCPAP, BPD, nCPAP, NRDS, ROP
25  2018 [Comparison of clinical efficacy of two noninvasive respiratory support therapies for respiratory distress syndrome in very low birth weight preterm infants]. HHHFNC, NIPPV, RDS, VLBW
26  2017 Clinical effects of pulmonary surfactant in combination with nasal continuous positive airway pressure therapy on neonatal respiratory distress syndrome. nCPAP, NRDS
27  2017 Effect of pulmonary surfactant combined with mechanical ventilation on oxygenation functions and expressions of serum transforming growth factor-beta1 (TGF-beta1) and bone morphogenetic protein 7 (BMP-7) of neonatal respiratory distress syndrome. ARDS, BMP-7, CMV, ELISA, NRDS, OI, RI, TGF-beta1
28  2017 Efficacy study of pulmonary surfactant combined with assisted ventilation for acute respiratory distress syndrome management of term neonates. RDS
29  2017 Human amniotic membrane as newly identified source of amniotic fluid pulmonary surfactant. HAM
30  2017 Pulmonary surfactant synthesis in miRNA-26a-1/miRNA-26a-2 double knockout mice generated using the CRISPR/Cas9 system. AECIIs, RDS
31  2017 Unveiling the Molecular Structure of Pulmonary Surfactant Corona on Nanoparticles. NPs
32  2017 [Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants]. BPD, NRDS, OI, VLBW
33  2016 Development of a Synthetic Surfactant Using a Surfactant Protein-C Peptide Analog: In Vitro Studies of Surface Physical Properties. PNBS, SP, SPa-C, sSP-C PS, STs
34  2016 Effect of pulmonary surfactant on the dissolution, stability and uptake of zinc oxide nanowires by human respiratory epithelial cells. NPs, ZnO NWs
35  2016 Fluidizing and Solidifying Effects of Perfluorooctylated Fatty Alcohols on Pulmonary Surfactant Monolayers. FC, NRDS
36  2016 Peptide-based synthetic pulmonary surfactant for the treatment of respiratory distress disorders. ---
37  2016 [Clinical effect of high-frequency oscillatory ventilation combined with pulmonary surfactant in treatment of neonatal severe meconium aspiration syndrome complicated by pulmonary hemorrhage]. HFOV, MAS, NPH, OI
38  2016 [Clinical efficacy of porcine pulmonary surfactant combined with budesonide suspension intratracheal instillation in the treatment of neonatal meconium aspiration syndrome]. MAS
39  2016 [Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis]. BPD, NRDS
40  2016 [Factors influencing the prognosis of patent ductus arteriosus in very low birth weight infants]. PDA, VLBW
41  2016 [Pulmonary surfactant homeostasis associated genetic abnormalities and lung diseases]. AEII
42  2015 A pilot study of less invasive surfactant administration in very preterm infants in a Chinese tertiary center. BPD, LISA, MV, nCPAP
43  2015 Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy. RNAi, siRNA
44  2015 Biophysical influence of airborne carbon nanomaterials on natural pulmonary surfactant. CDS, CNM, NP, OELs
45  2015 Delineation of the dynamic properties of individual lipid species in native and synthetic pulmonary surfactants. SP-B
46  2015 Effects of graphene oxide nanosheets on the ultrastructure and biophysical properties of the pulmonary surfactant film. GO
47  2015 Effects of nanoparticles on the mechanical functioning of the lung. ---
48  2015 Efficiency of high-frequency oscillatory ventilation combined with pulmonary surfactant in the treatment of neonatal meconium aspiration syndrome. CMV, HFOV, MAS, NICU, OI
49  2015 Pneumocytes Assemble Lung Surfactant as Highly Packed/Dehydrated States with Optimal Surface Activity. LBPs, LBs
50  2015 Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition. NPs
51  2015 The antimicrobial effect of colistin methanesulfonate on Mycobacterium tuberculosis invitro. CMS, MABA, Mtb, RIF
52  2015 [Clinical efficacy of high-frequency oscillatory ventilation combined with pulmonary surfactant in treatment of neonatal pulmonary hemorrhage]. HFOV, NPH, OI
53  2015 [Clinical features, prevention and treatment of respiratory distress syndrome in neonates of different gestational ages in tertiary hospitals in Northwest China]. GA, RDS
54  2015 [Effects of exogenous pulmonary surfactant on acute lung injury in rats with severe burn-blast combined injury]. ---
55  2015 [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China]. ART, BW, GA, INSURE, NICUs, RDS
56  2015 [Expression profile of TGF-beta1 and BMP-7 in serum of preterm infants with respiratory distress syndrome]. BMP-7, RDS, TGF-beta1
57  2015 [The clinical comparative study of preterm respiratory distress syndrome and transient tachypnea of newborn]. OI, RDS, TTN
58  2014 Amyloid-beta (1-40) restores adhesion properties of pulmonary surfactant, counteracting the effect of cholesterol. ALI, ARDS
59  2014 Early prophylactic versus late selective use of surfactant for respiratory distress syndrome in very preterm infants: a collaborative study of 53 multi-center trials in Korea. EP, LS
60  2014 Nontoxic impact of PEG-coated gold nanospheres on functional pulmonary surfactant-secreting alveolar type II cells. ATII, NPs, PEG
61  2014 Physiological variables affecting surface film formation by native lamellar body-like pulmonary surfactant particles. ALI, LBPs, LBs
62  2014 Promote potential applications of nanoparticles as respiratory drug carrier: insights from molecular dynamics simulations. DPPC, NPs
63  2014 Understanding the mutual impact of interaction between hydrophobic nanoparticles and pulmonary surfactant monolayer. NPs
64  2014 [A population-based epidemiological survey of neonatal respiratory failure in Huai'an City of Jiangsu Province, in 2010]. NRF
65  2014 [Clinical application of nasal intermittent positive pressure ventilation in initial treatment of neonatal respiratory distress syndrome]. nCPAP, NIPPV, NRDS
66  2014 [Clinical effect of endotracheal lavage with porcine pulmonary surfactant in term neonates with severe meconium aspiration syndrome]. MAS, OI
67  2014 [Early use of calf pulmonary surfactant in late preterm and full-term infants with respiratory distress syndrome: a randomized controlled trial]. OI, RDS
68  2014 [Relationship between recovery levels of pulmonary surfactants and lung compliance after whole-lung lavage]. ---
69  2013 Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles. MM, NPs
70  2013 Effects of a novel antimycobacterial compound on the biophysical properties of a pulmonary surfactant model membrane. BAM, DLS, DPPC, PM-IRRAS
71  2013 Interplay of mycolic acids, antimycobacterial compounds and pulmonary surfactant membrane: a biophysical approach to disease. MAs, Mtb, TB
72  2013 Pathological study of otitis media with effusion after treatment with intranasal pulmonary surfactant. ABR, ET, OME
73  2013 [Clinical effect of combination therapy with high-frequency oscillation ventilation, pulmonary surfactant and inhaled nitric oxide in the treatment of neonatal hypoxemic respiratory failure]. HFOV, HRF, iNO, OI, PA, PPHN
74  2012 Enhanced pulmonary absorption of recombinant human insulin by pulmonary surfactant and phospholipid hexadecanol tyloxapol through Calu-3 monolayers. PHT, rhINS
75  2012 Expression of SP-C and Ki67 in lungs of preterm infants dying from respiratory distress syndrome. RDS, SP-C
76  2012 Therapeutic effects of inhaling aerosolized surfactant alone or with dexamethasone generated by a novel noninvasive apparatus on acute lung injury in rats. ALI, BALF, DEX, NS
77  2012 [Comparisons of efficacy of different pulmonary surfactants for the treatment of neonatal respiratory distress syndrome]. NRDS
78  2012 [Effect of L-arginine on pulmonary surfactant and alveolar macrophages in rats with pulmonary injury induced by lipopolysaccharide]. ALI, AM, BALF, IL-6, L-Arg, LDH, LPS, NO, SP-A, TNF-alpha, TP
79  2012 [Effect of pulmonary surfactant on Th1/Th2 balance in neonates with respiratory distress syndrome]. IFN-gamma, IL-4, RDS
80  2012 [Efficacy of pulmonary surfactant therapy in neonates with meconium aspiration syndrome: a meta-analysis]. MAS, RCTs
81  2012 [Prospective study on in-hospital mortality and its risk factors in very low birth weight infants requring mechanical ventilation]. CRIB, NICU, SNAPPE-II, VLBWIs
82  2011 Adverse biophysical effects of hydroxyapatite nanoparticles on natural pulmonary surfactant. HA-NPs, NPs
83  2011 Intra-amniotic administration of exogenous pulmonary surfactant for improving in lung maturity of fetal rabbits with intrauterine infection caused by premature rupture of membranes. ATII, PROM
84  2011 The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats. AT2, BALF, DPPC, PA, TP, TPL
85  2011 [Effects of hydrogen sulfide on pulmonary surfactant in rats with acute lung injury induced by lipopolysccharide]. AECII, ALI, BLAF, CSE, LPS, PPG, SP-A, SP-B, SP-C, TP, TPL
86  2010 Effect of cholesterol on electrostatics in lipid-protein films of a pulmonary surfactant. FM-KPFM
87  2010 Effect of pulmonary surfactant and phospholipid hexadecanol tyloxapol on recombinant human-insulin absorption from intratracheally administered dry powders in diabetic rats. AAC, AKP, BAL, LDH, NAG, PHT, rh-insulin
88  2010 Fluorocarbon-hybrid pulmonary surfactants for replacement therapy--a Langmuir monolayer study. DPPC, LC, LE, PFA, RDS
89  2010 Interfacial reactions of ozone with surfactant protein B in a model lung surfactant system. FIDI, POG, SP-B
90  2010 Vasoactive intestinal peptide induces surfactant protein A expression in ATII cells through activation of PKC/c-Fos pathway. ATII, SP-A, VIP
91  2010 [Effect of NG-nitro-L-arginine on pulmonary surfactant and pulmonary apoptosis in acute lung injury induced by lipopolysaccharide]. ALI, IHC, ISH, L-NA, LPS, SD, SP-A
92  2010 [Effects of positive end expiratory pressure on pulmonary surfactant in patients undergoing one-lung ventilation]. BALF, Sat PC, TP, TPL
93  2009 A quantitative assessment of inhaled drug particle-pulmonary surfactant interaction by atomic force microscopy. AFM, LB
94  2009 Depressed exocytosis and endocytosis of type II alveolar epithelial cells are responsible for the surfactant deficiency in the lung of newborn with congenital diaphragmatic hernia. AEC II
95  2009 Effect of SP-C on surface potential distribution in pulmonary surfactant: Atomic force microscopy and Kelvin probe force microscopy study. AFM, BLES, KPFM, SP-C
96  2009 Surfactant therapy for neonatal respiratory distress syndrome: a review of Korean experiences over 17 years. RDS
97  2009 The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery. ---
98  2009 [Effects of high frequency oscillatory ventilation and its combination with pulmonary surfactant treatment on inflammatory response in rabbit lung with inhalation injury]. caspase-1, HFOV, MPO
99  2009 [Exogenous pulmonary surfactant replacement combined with recruitment maneuver in prevention of alveolar derecruitment in rabbits with acute respiratory distress syndrome]. ARDS, Cst, PIP, RM, VALI
100  2009 [Experimental research of prevention and therapy effect of anisodamine on acute respiratory distress syndrome (ARDS)]. ACP, ARDS, FN, LDH, MDA, OA, SOD